Mpande Mukumbwa-Mwenechanya

Author

Centre for Infectious Disease Research in Zambia ORCID

Also Known As

Mpande M Mwenechanya, Mpande M. Mwenechanya, Mpande Mukumbwa Mwenechanya, Mpande Mukumbwa-Mwenechanya, Mpande Mukumbwa-Mwenechanya (9073164), Rose Nyandera, Savory T.

Publications

258

Citations

H-Index

Concepts

All Affiliations

Centre for Infectious Disease Research in Zambia Ministry of Health Boston University University of the Witwatersrand University of California, San Francisco

About

Mpande Mukumbwa-Mwenechanya is an author at Centre for Infectious Disease Research in Zambia specializing in medicine, epidemiology, and international health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	31
2	Public Health	2	2	31
3	Epidemiology	2	2	31
4	Global Health	2	2	31
5	Health Informatics	1	1	17

Mpande Mukumbwa-Mwenechanya

Publications

193

Citations

H-Index

Page 1

	Year	Citations
Differentiated Care Preferences of Stable Patients on Antiretroviral Therapy in Zambia: A Discrete Choice Experiment Ingrid Eshun‐Wilson, Mpande Mukumbwa-Mwenechanya, Hae‐Young Kim, JAIDS Journal of Acquired Immune Deficiency Syndromes	2019	84
Participation in adherence clubs and on-time drug pickup among HIV-infected adults in Zambia: A matched-pair cluster randomized trial Monika Roy, Carolyn Bolton‐Moore, Izukanji Sikazwe, PLoS Medicine	2020	18
Changes in HIV treatment differentiated care uptake during the COVID‐19 pandemic in Zambia: interrupted time series analysis Youngji Jo, Sydney Rosen, Karla Therese L. Sy, Journal of the International AIDS Society	2021	17
The integration of tuberculosis and HIV testing on GeneXpert can substantially improve access and same-day diagnosis and benefit tuberculosis programmes: A diagnostic network optimization analysis in Zambia Sarah Girdwood, Mayank Pandey, Trevor Machila, PLOS Global Public Health Point-of-care TestingDiagnostic Network OptimizationTuberculosis PreventionDiagnosisDiagnostics	2023	17
Mitigating the effects of COVID-19 on HIV treatment and care in Lusaka, Zambia: a before–after cohort study using mixed effects regression Jake M. Pry, Kombatende Sikombe, Aaloke Mody, BMJ Global Health	2022	16
How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? Evidence from a retrospective cohort study in Zambia Lise Jamieson, Sydney Rosen, Bevis Phiri, BMJ Open	2022	16
Community pharmacists’ knowledge and preparedness to participate in the fight against Coronavirus disease 2019 (COVID-19) in Zambia Jimmy Mapenzi Hangoma, Steward Mudenda, Mpande Mukumbwa-Mwenechanya, National GuidelinesCommunity PharmacistsCovid-19 EpidemiologyCovid-19Preventive Medicine	2020	14
Attrition from HIV treatment after enrollment in a differentiated service delivery model: A cohort analysis of routine care in Zambia Youngji Jo, Lise Jamieson, Bevis Phiri, PLoS ONE	2023	11

Page 1